CD274 and breast neoplasm: For example, breast tumors that survive chemotherapy exhibit an interferon-response gene signature characterized by elevated PD-L1 levels, resulting from chemotherapy-induced chromatin modifications that facilitate the recruitment of the IRF1 transcription factor to the PD-L1 gene promoter [126].